📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis. (2019)

First Author: Picconi P

Attributed to: KCL Confidence in Concept 2013 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acsomega.9b00834

PubMed Identifier: 31867477

Publication URI: http://europepmc.org/abstract/MED/31867477

Type: Journal Article/Review

Volume: 4

Parent Publication: ACS omega

Issue: 25

ISSN: 2470-1343